GENELUX CORPORATION Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
GENELUX CORPORATION (GNLX) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $1.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2026-08-13
- GENELUX CORPORATION adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2026-06-30 was $1.42M, a 9.84% increase year-over-year.
- GENELUX CORPORATION adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2026-03-31 was $1.39M, a 2.04% decline year-over-year.
- GENELUX CORPORATION adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2025-06-30 was $1.29M.
- GENELUX CORPORATION adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2025-03-31 was $1.42M.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month |
|---|---|---|
| 2026-06-30 | $1.42M 10-Q · filed 2026-08-13 | $2.81M derived: sum of 2 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.39M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $1.29M 10-Q · filed 2026-08-13 | $2.71M derived: sum of 2 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.42M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |